FI80475C - Foerfarande foer framstaellning av ett tumoerhaemmande antibioticum, sandramycin. - Google Patents

Foerfarande foer framstaellning av ett tumoerhaemmande antibioticum, sandramycin. Download PDF

Info

Publication number
FI80475C
FI80475C FI852082A FI852082A FI80475C FI 80475 C FI80475 C FI 80475C FI 852082 A FI852082 A FI 852082A FI 852082 A FI852082 A FI 852082A FI 80475 C FI80475 C FI 80475C
Authority
FI
Finland
Prior art keywords
sandramycin
medium
strain
chloroform
residue
Prior art date
Application number
FI852082A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI852082L (fi
FI852082A0 (fi
FI80475B (fi
Inventor
James A Matson
James A Bush
Original Assignee
Squibb Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb Bristol Myers Co filed Critical Squibb Bristol Myers Co
Publication of FI852082A0 publication Critical patent/FI852082A0/fi
Publication of FI852082L publication Critical patent/FI852082L/fi
Publication of FI80475B publication Critical patent/FI80475B/fi
Application granted granted Critical
Publication of FI80475C publication Critical patent/FI80475C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/19—Antibiotic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
FI852082A 1984-06-18 1985-05-24 Foerfarande foer framstaellning av ett tumoerhaemmande antibioticum, sandramycin. FI80475C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62164184 1984-06-18
US06/621,641 US4582639A (en) 1984-06-18 1984-06-18 Antitumor antibiotic compound

Publications (4)

Publication Number Publication Date
FI852082A0 FI852082A0 (fi) 1985-05-24
FI852082L FI852082L (fi) 1985-12-19
FI80475B FI80475B (fi) 1990-02-28
FI80475C true FI80475C (fi) 1990-06-11

Family

ID=24491001

Family Applications (1)

Application Number Title Priority Date Filing Date
FI852082A FI80475C (fi) 1984-06-18 1985-05-24 Foerfarande foer framstaellning av ett tumoerhaemmande antibioticum, sandramycin.

Country Status (23)

Country Link
US (1) US4582639A (2)
JP (1) JPS6122099A (2)
KR (1) KR930003107B1 (2)
AT (1) AT395860B (2)
AU (1) AU584075B2 (2)
BE (1) BE902670A (2)
CA (1) CA1230568A (2)
CH (1) CH668974A5 (2)
DE (1) DE3521436A1 (2)
DK (1) DK272985A (2)
ES (1) ES8609485A1 (2)
FI (1) FI80475C (2)
FR (1) FR2568892B1 (2)
GB (1) GB2160529B (2)
GR (1) GR851452B (2)
IE (1) IE58629B1 (2)
IT (1) IT1191622B (2)
LU (1) LU85953A1 (2)
MY (1) MY100478A (2)
NL (1) NL8501708A (2)
PT (1) PT80656B (2)
SE (1) SE464524B (2)
ZA (1) ZA852370B (2)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902781A (en) * 1987-11-24 1990-02-20 Taisho Pharmaceutical Co., Ltd. Novel tripetide derivatives
DE3832362A1 (de) * 1988-09-23 1990-03-29 Sandoz Ag Neue cyclopeptolide, verfahren zu ihrer herstellung und ihre verwendung
US5516676A (en) * 1993-06-15 1996-05-14 Bristol-Myers Squibb Company Preparation of C-13 hydroxyl-bearing taxanes using nocardioides or a hydrolase isolated therefrom
US5523219A (en) * 1993-06-15 1996-06-04 Bristol-Myers Squibb Company Enzymatic hydrolysis method for the preparation of C-10 hydroxyl-bearing taxanes and enzymatic esterification method for the preparation of C-10 acyloxy-bearing
US5643871A (en) * 1993-11-23 1997-07-01 Bristol-Meyers Squibb Company Antitumor antibiotics
US5444043A (en) * 1994-02-18 1995-08-22 The Regents Of The University Of California Cyclic heptapeptide anti-inflammatory agent
GB2294265A (en) * 1994-10-20 1996-04-24 Merck & Co Inc Cyclic depsipeptides obtained from Actinomycete sp.
CA2285259A1 (en) * 1997-03-28 1998-10-08 The Scripps Research Institute Sandramycin analogs
US6001815A (en) * 1997-12-25 1999-12-14 Nisshin Flour Milling Co., Ltd. Depsipeptides containing N-substituted glycine residue
KR100575681B1 (ko) 2004-05-18 2006-05-03 엘지전자 주식회사 와인 냉장고의 진동절연 지지장치
WO2007024574A2 (en) * 2005-08-19 2007-03-01 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Topical formulations of histone deacetylase inhibitors and methods of using the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451456A (en) * 1979-04-02 1984-05-29 Bristol-Myers Company Antitumor antibacterial agents
US4360458A (en) * 1979-04-02 1982-11-23 Bristol-Myers Company Antitumor antibacterial agents

Also Published As

Publication number Publication date
FI852082L (fi) 1985-12-19
FR2568892A1 (fr) 1986-02-14
IT8521156A0 (it) 1985-06-14
GB2160529A (en) 1985-12-24
ATA178285A (de) 1992-08-15
CA1230568A (en) 1987-12-22
GR851452B (2) 1985-11-25
GB8515256D0 (en) 1985-07-17
PT80656B (pt) 1988-01-22
DE3521436C2 (2) 1993-08-05
IE58629B1 (en) 1993-10-20
ES544289A0 (es) 1986-09-01
DE3521436A1 (de) 1985-12-19
US4582639A (en) 1986-04-15
GB2160529B (en) 1987-10-07
SE464524B (sv) 1991-05-06
DK272985A (da) 1985-12-19
ES8609485A1 (es) 1986-09-01
IE851504L (en) 1985-12-18
AT395860B (de) 1993-03-25
LU85953A1 (fr) 1986-01-24
NL8501708A (nl) 1986-01-16
MY100478A (en) 1990-10-15
SE8502996L (sv) 1985-12-19
KR930003107B1 (ko) 1993-04-19
JPH0158200B2 (2) 1989-12-11
FI852082A0 (fi) 1985-05-24
FI80475B (fi) 1990-02-28
AU584075B2 (en) 1989-05-18
PT80656A (en) 1985-07-01
JPS6122099A (ja) 1986-01-30
BE902670A (fr) 1985-12-17
FR2568892B1 (fr) 1990-02-09
CH668974A5 (de) 1989-02-15
ZA852370B (en) 1985-11-27
AU4048085A (en) 1986-01-02
KR860000382A (ko) 1986-01-28
IT1191622B (it) 1988-03-23
DK272985D0 (da) 1985-06-17
SE8502996D0 (sv) 1985-06-17

Similar Documents

Publication Publication Date Title
FI77264C (fi) Foerfarande foer framstaellning av rebeccamycin med antitumoer effekt.
US4518589A (en) BBM-2478 Antibiotic complex
FI80475C (fi) Foerfarande foer framstaellning av ett tumoerhaemmande antibioticum, sandramycin.
US4524145A (en) 4'-Deschlororebeccamycin pharmaceutical composition and method of use
EP0388956A2 (en) Phthalinide derivative, pharmaceutical composition and use
US4567143A (en) Process for preparing 4'-deschlororebeccamycin
US4792522A (en) Rigolettone antitumor complex
US4599310A (en) Process for producing antitumor antibiotic compound
EP0444503A2 (en) Staurosporine fermentation process
US4301248A (en) Fermentation process for making rachelmycin
JP3830964B2 (ja) 海洋放線菌から単離した新規なチオデプシペプチド
US4572895A (en) Process for preparing an antibiotic complex by culturing actinomyces strain ATCC 39417
AU682543B2 (en) Antitumor antibiotics
US4883758A (en) Biologically pure culture of the microorganism Streptomycas tropolofaciens used for producing 3,7-dihydroxytropolone and antitumor use
US5002959A (en) BU-4146T antibiotic
US4956374A (en) Polysubstituted thiazolylpyridine carboxyamide antifungal antibiotic
CA2020878C (en) Antitumor antibiotic bu-3285t
EP0501399A1 (en) Physiologically active kanglemycin C, process for preparing the same and use thereof
US5811440A (en) Antitumor antibiotic BMS-199687
US5037836A (en) BU-4146T antibiotic
EP0431323A1 (en) Antitumor antibiotic BU-3983T

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: BRISTOL-MYERS SQUIBB COMPANY